Retraction Retraction dated 2023-03-24
Click to view Retraction: https://doi.org/10.1186/s13048-023-01138-w
-
Authors
Chhabria, Sagar
Takle, Vaishnavi
Sharma, Nripen
Kharkar, Prashant
Pansare, Kshama
Tripathi, Anish
Tripathi, Ashish
Bhartiya, Deepa https://orcid.org/0000-0002-5384-3998
-
Funding
Funding for this research was provided by:
Epigeneres Biotech Pvt Ltd (na)
Epigeneres Biotech Pvt Ltd (na)
Epigeneres Biotech Pvt Ltd (na)
- License Information
-
More Information
Article History
Received: 30 May 2022
Accepted: 23 September 2022
First Online: 21 October 2022
Change Date: 24 March 2023
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1186/s13048-023-01138-w
Declarations
:
: The animal study protocol of the current investigation was approved by the Institutional Animal Ethics Committee of SVKM’s NMIMS University, Mumbai, India (IAEC/P-16/2017).
: EPI/RA/01/2022.
: XAR™ is a nano-formulation of resveratrol patented and manufactured by Epigeneres Biotech Pvt. Ltd.
